3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
20
Recurrence
4
Neoplasms
3
Plasmablastic Lymphoma
2
Leukemia, Myeloid, Acute
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmacytoma
1
Myelodysplastic Syndromes
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Plasma Cell
1
Interventions
venetoclax
5
Rituximab
4
Cyclophosphamide
4
Whole-Body Irradiation
3
Cyclosporine
3
zanubrutinib
2
pirtobrutinib
2
fludarabine phosphate
2
fludarabine
2
Prednisone
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
treosulfan
1
pomalidomide
1
obinutuzumab
1
ibrutinib
1
Vincristine
1
Tacrolimus
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
R-CHOP protocol
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Methotrexate
1
Melphalan
1
Maintenance
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
daratumumab
×
30 days
×
Clear all
No trials found.